Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy?

Korean Circ J · 2023 · PMC10475692 · PMID 37653697

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

They also showed that the use of RASi may be associated with favorable clinical outcomes in patients without left ventricular outflow tract obstruction (LVOTO), although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.